NVCR
Novocure Ltd
NASDAQ: NVCR · HEALTHCARE · MEDICAL DEVICES
$15.21
+27.49% today
Updated 2026-04-30
Market cap
$1.38B
P/E ratio
—
P/S ratio
2.11x
EPS (TTM)
$-1.22
Dividend yield
—
52W range
$10 – $20
Volume
1.6M
Novocure Ltd (NVCR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $188.91M | $117.88M | $307.34M | $282.08M | $265.30M | $339.79M | $479.45M | $1.05B | $1.14B | $1.19B | $1.15B | $1.24B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $183.48M | $111.83M | $293.90M | $261.87M | $245.13M | $321.37M | $439.95M | $999.44M | $1.07B | $1.11B | $1.03B | $1.11B |
| Total liabilities | $17.13M | $20.00M | $56.52M | $139.74M | $151.73M | $227.53M | $261.66M | $575.46M | $729.00M | $750.48M | $783.63M | $880.61M |
| Current liabilities | $15.60M | $17.67M | $28.63M | $36.88M | $50.20M | $64.56M | $86.31M | $113.61M | $142.60M | $158.78M | $179.12M | $756.38M |
| Long-term debt | $346000.00 | $321000.00 | $23.35M | $96.23M | $97.96M | $149.27M | $149.42M | $429.90M | $562.22M | $565.51M | $568.82M | $97.30M |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-195.82M | $-276.50M | $-388.08M | $-519.93M | $-582.26M | $-643.65M | $-650.88M | $-631.08M | $-685.93M | $-778.46M | $-985.50M | $-1.15B |
| Accounts receivable | $3.88M | $4.86M | $10.80M | $16.42M | $37.67M | $36.52M | $88.06M | $100.47M | $110.59M | $112.22M | $77.11M | $102.07M |
| Inventory | $1.89M | $3.45M | $13.59M | $25.55M | $22.02M | $22.55M | $23.70M | $27.42M | $24.43M | $29.38M | $38.15M | $35.09M |
| Goodwill | — | — | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |